US Stock MarketDetailed Quotes
ICU SeaStar Medical
- 7.0000
- -0.5200-6.91%
Trading Jul 24 13:10 ET
29.18MMarket Cap-325P/E (TTM)
7.4000High6.8200Low109.54KVolume7.1700Open7.5200Pre Close765.50KTurnover2.71%Turnover RatioLossP/E (Static)4.17MShares42.922552wk High-6.52P/B28.32MFloat Cap3.250052wk Low--Dividend TTM4.05MShs Float550.0000Historical High--Div YieldTTM7.71%Amplitude3.2500Historical Low6.9880Avg Price1Lot Size
SeaStar Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 509.37%9.39M | -31.96%-10.29M | -1.66%-5.39M | 745.51%5.9M | -118.87%-2.17M | -290.80%-2.29M | -52.41%-7.79M | -5.3M | -914K | -3.34%-991K |
| Net income from continuing operations | -243.53%-24.38M | -115.19%-26.23M | -155.00%-21.4M | -1,777.85%-35.53M | -103.44%-1.84M | -606.77%-7.1M | -165.23%-12.19M | ---8.39M | ---1.89M | 18.44%-902K |
| Operating gains losses | 1,447.06%1.83M | 11,524.00%5.71M | -209.47%-578K | -8,063.46%-4.25M | 338.58%1.38M | -361.54%-136K | 21.88%-50K | --528K | ---52K | ---578K |
| Depreciation and amortization | --1.03M | ---- | --1.03M | --1.04M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non cash items | 86.41%4.14M | -91.77%48K | 3,176.00%3.28M | 6,343.75%5.16M | -1,954.50%-3.51M | 938.32%2.22M | 175.00%583K | --100K | --80K | --189K |
| Change In working capital | 949.53%23.21M | 12.74%2.88M | 357.46%8.5M | 6,598.48%39.72M | 5,722.73%1.24M | 1,683.06%2.21M | 475.29%2.55M | --1.86M | --593K | -116.18%-22K |
| -Change in receivables | 40,575.00%4.88M | 200.00%12K | -454,325.00%-18.17M | --11.14M | --0 | --12K | --4K | --4K | --0 | --0 |
| -Change in inventory | --726K | ---- | ---273K | ---833K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | -112.26%-39K | 90.96%-97K | -41.40%-1.51M | 39.66%1.08M | 157.43%340K | 271.89%318K | -9,041.67%-1.07M | ---1.07M | --774K | -4,653.85%-592K |
| -Change in payables and accrued expense | 1,531.14%17.86M | -18.20%2.96M | 1,390.35%28.59M | 3,360.07%28.51M | 195.26%1.68M | 254.37%1.1M | 584.74%3.62M | --1.92M | --824K | 363.41%570K |
| -Change in other current assets | ---30K | ---- | --51K | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | -124.68%-194K | ---- | ---186K | ---177K | ---- | --786K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 509.37%9.39M | -31.96%-10.29M | -1.66%-5.39M | 745.51%5.9M | -118.87%-2.17M | -290.80%-2.29M | -52.41%-7.79M | ---5.3M | ---914K | -3.34%-991K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -150K | -167K | -155K | |||||||
| Net PPE purchase and sale | ---- | ---- | ---1K | ---21K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net intangibles purchase and sale | ---150K | ---- | ---166K | ---134K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---150K | ---- | ---167K | ---155K | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -476.72%-11.2M | 42.05%10.41M | 56.72%8.31M | -11,211.71%-38.89M | 4.29%1.46M | 946.48%2.97M | 160.24%7.33M | 5.3M | 350K | 190.44%1.4M |
| Net issuance payments of debt | -4,173.08%-20.12M | 1.41%3.53M | -72.21%403K | -11,152.86%-38.69M | 0.36%1.4M | 73.94%494K | 23.57%3.48M | --1.45M | --350K | 190.44%1.4M |
| Net common stock issuance | 241.03%10.16M | -33.89%6.61M | -21.32%7.87M | --1.42M | --55K | --2.98M | --10M | --10M | --0 | --0 |
| Proceeds from stock option exercised by employees | --46K | 115.63%772K | --34K | --358K | ---- | --0 | ---4.94M | ---- | ---- | ---- |
| Net other financing activities | -155.40%-1.28M | 58.71%-500K | --0 | ---1.99M | --0 | ---500K | ---1.21M | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -476.72%-11.2M | 42.05%10.41M | 56.72%8.31M | -11,211.71%-38.89M | 4.29%1.46M | 946.48%2.97M | 160.24%7.33M | --5.3M | --350K | 190.44%1.4M |
| Net cash flow | ||||||||||
| Beginning cash position | 9,961.70%4.73M | -90.78%47K | 3,940.82%1.98M | 5,630.18%35.13M | 250.24%725K | -90.78%47K | -81.83%510K | --49K | --613K | -81.28%207K |
| Current changes in cash | -388.35%-1.96M | 127.86%129K | 137,550.00%2.75M | -5,776.95%-33.15M | -275.37%-712K | 323.76%678K | 79.84%-463K | ---2K | ---564K | 184.94%406K |
| End cash Position | 282.62%2.77M | 274.47%176K | 9,961.70%4.73M | 3,940.82%1.98M | -97.88%13K | 250.24%725K | -90.78%47K | --47K | --49K | -2.39%613K |
| Free cash flow | 502.83%9.24M | -31.96%-10.29M | -4.81%-5.56M | 728.56%5.75M | -118.87%-2.17M | -290.80%-2.29M | -52.41%-7.79M | ---5.3M | ---914K | -3.34%-991K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg